Epithalon vs MOTS-c
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Epitalon, Epithalone
Epithalon (also spelled Epitalon) is a synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly (AEDG), modeled on a natural pineal gland extract. It came out of decades of Russian gerontology research led by Vladimir Khavinson and is marketed as an anti-aging compound that supposedly switches telomerase back on. It has no approval from the FDA, EMA, or other Western regulators, and the human evidence is thin.
Also: Mitochondrial ORF of the 12S rRNA type-c
MOTS-c is a 16-amino-acid peptide your own mitochondria make, encoded inside the 12S rRNA region of mitochondrial DNA and discovered in 2015. It is studied as a metabolic regulator and a so-called exercise mimetic, because its levels rise when you work out and it improves insulin sensitivity in animals. The catch: the impressive results are almost entirely in mice, with no completed published human efficacy trials.
Key Comparison Insights
- Epithalon is categorized as Bioregulators, while MOTS-c is Hormonal.
- Epithalon has stronger research evidence (Human Trials) compared to MOTS-c (Animal Studies).
Detailed Comparison
| Attribute | Epithalon | MOTS-c |
|---|---|---|
| Category | Bioregulators | Hormonal |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | The headline claim is telomerase activation. Telomerase is the enzyme that rebuilds telomeres, the protective caps on chromosome ends that shorten as cells divide and age. In cell cultures, Epithalon appears to switch on telomerase in cells that normally lack it, allowing telomeres to lengthen. It is also proposed to influence melatonin production, antioxidant defenses, and gene expression in the pineal-hypothalamic axis. These are real findings in dishes and animals, but the leap from a telomerase signal in a petri dish to actually slowing human aging is a hypothesis, not a proven mechanism. | MOTS-c works largely through the AMPK pathway, the cell's main energy and fuel-gauge system. The proposed route is that MOTS-c interferes with the folate-AICAR-one-carbon metabolism cycle, which raises AICAR and activates AMPK in skeletal muscle, liver, and fat. Once AMPK is switched on, cells burn more fatty acids, take up more glucose, and ramp up mitochondrial biogenesis. MOTS-c can also move into the cell nucleus under metabolic stress and influence stress-response genes, which is unusual for a mitochondrial peptide and is part of why it is framed as a stress-adaptive signal. Treat the exact pathway details as a working model rather than settled fact, since much of it is still being mapped. |
| Common Dosing | 5-10 mg daily for 10-20 days Once daily in cycles | 5-10 mg weekly 1-3x weekly |
| Administration | Subcutaneous or intramuscular injection | Subcutaneous injection |
| Typical Duration | 10-20 day cycles | Variable by protocol |
| Best Time to Take | Before bed | Morning or pre-workout |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The cell-level evidence is the strongest part of the story. Khavinson and colleagues (Bulletin of Experimental Biology and Medicine, 2003) showed Epithalon induced telomerase activity and elongated telomeres in cultured human fibroblasts, and a 2025 review in the International Journal of Molecular Sciences summarized its geroprotective and neuroendocrine effects. Animal studies from the same Russian groups reported longer lifespan and reduced tumor incidence in mice and rats. The problem is the human side: replication outside those groups is limited to small, often open-label studies and case reports, with no large, independent, placebo-controlled trials proving it extends human lifespan or reliably lengthens telomeres in people. Its safety record in the published literature looks clean at research doses, but clean and unapproved are not the same as proven. So the honest read is promising preclinical data, real research lineage, and unproven human benefit. | In mice, MOTS-c is genuinely impressive: it improves insulin sensitivity, protects against diet-induced obesity, and older animals given MOTS-c run longer on a treadmill, which is where the exercise-mimetic label comes from. The human story is much thinner. The strongest human finding is observational: exercise raises MOTS-c, with reports of roughly a 12-fold jump in skeletal muscle and about a 1.6-fold rise in circulation after exercise, suggesting it may be one natural messenger behind some exercise benefits. But that is correlation, not proof that injecting MOTS-c reproduces those benefits. As of 2026 there are no completed, published randomized human trials showing that supplemental MOTS-c causes weight loss, better metabolic health, or longer life in people. It is also a known anti-doping target, which tells you it is treated as experimental and performance-relevant, not as an established therapy. |
Frequently Asked Questions: Epithalon vs MOTS-c
What is the difference between Epithalon and MOTS-c?
Epithalon is a bioregulators peptide that epithalon (also spelled epitalon) is a synthetic four-amino-acid peptide, ala-glu-asp-gly (aedg), modeled on a natural pineal gland extract. it came out of decades of russian gerontology research led by vladimir khavinson and is marketed as an anti-aging compound that supposedly switches telomerase back on. it has no approval from the fda, ema, or other western regulators, and the human evidence is thin. MOTS-c is a hormonal peptide that mots-c is a 16-amino-acid peptide your own mitochondria make, encoded inside the 12s rrna region of mitochondrial dna and discovered in 2015. it is studied as a metabolic regulator and a so-called exercise mimetic, because its levels rise when you work out and it improves insulin sensitivity in animals. the catch: the impressive results are almost entirely in mice, with no completed published human efficacy trials. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Epithalon or MOTS-c?
Neither is universally "better" - the choice depends on your specific goals. Epithalon is typically used for bioregulators purposes, while MOTS-c is used for hormonal. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Epithalon and MOTS-c be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Epithalon and MOTS-c together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.